Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received expanded CE mark for its automated insulin delivery (AID) systems. San Diego-based Tandem can now bring its Control-IQ-powered AID systems — the flagship t:slim X2 and miniature Mobi — to European adults with type 2 diabetes and those with type 1 diabetes during pregnancy. Approval in […]
Women's Health
Tandem wins FDA clearance for automated insulin delivery in pregnant women with type 1 diabetes
Tandem Diabetes Care (Nasdaq:TNDM) today announced FDA clearance for its automated insulin delivery (AID) technology for use in pregnancy. The FDA cleared the company’s Control-IQ AID technology for use in pregnancy complicated by type 1 diabetes mellitus. Control-IQ+ powers both of Tandem’s available t:slim X2 and Mobi AID systems. San Diego-based Tandem says t:slim X2 […]
Carrot, Oura, Dexcom partner on biosensor insights for fertility
Carrot announced that it partnered with Oura and Dexcom to deliver actionable, personalized insights supporting fertility goals. The companies came together to provide actionable, personalized insights through the metabolic-fertility program, Sprints. This collaboration combines Carrot’s clinical expertise with advanced insights from Oura, a leading smart wearable ring maker, and Dexcom, a leading continuous glucose monitor […]
NHS offers artificial pancreas to pregnant women with type 1 diabetes in the UK
The NHS announced a first-of-its-kind initiative in England, offering automated insulin delivery systems for pregnant women with diabetes. NHS said its local healthcare systems can offer enhanced hybrid closed-loop systems, also known as artificial pancreases, to women with type 1 diabetes who are pregnant or planning a pregnancy. This way, they can effectively manage their […]
Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes
A new study showed improved glucose control in pregnant women using Tandem Diabetes Care (Nasdaq:TNDM) insulin delivery technology. The study showed that pregnant women with type 1 diabetes stayed in the target glucose range for pregnancy more with the Tandem t:slim X2 automated insulin delivery system with Control-IQ technology compared to standard insulin delivery with injections […]
Researchers look to study automated insulin delivery in pregnant women with type 1 diabetes
Researchers and leading diabetes in pregnancy investigators say they opened an observational study of automated insulin delivery (AID) in pregnancy. A team from the Jaeb Center for Health Research, along with other investigators, seeks to evaluate AID in pregnancy with type 1 diabetes. They hope to facilitate a better understanding of real-world type 1 diabetes […]
Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
Nuvo Group announced today that it completed the first phase of a collaboration agreement with Sheba Medical Center’s “Sheba BEYOND.” The first phase of the partnership included a pilot program centered around gestational diabetes management. The program shifted necessary non-stress tests (NSTs) to home-based, remote monitoring using Nuvo’s INVU rather than conducting traditional monitoring in […]
NovaXS unveils prototype for smart, needle-free drug delivery device
NovaXS Biotech announced that it unveiled the new prototype for its needle-free injection therapy smart medical device. Formed at the University of California, Berkeley, NovaXS designed its patent-pending Telosis technology to administer a narrow stream of medication without a needle in 0.3 seconds and to analyze injection data to allow for smarter health decisions. The […]
ProMed Pharma begins preclinical testing of resorbable contraceptive implant
After receiving funding from the Bill & Melinda Gates Foundation, ProMed Pharma has begun preclinical evaluation of a novel fully resorbable contraceptive implant. The Plymouth, Minnesota–based company imagines that the contraceptive implants could ultimately find use in low- and middle-income (LMIC) settings. The novel implant potentially could offer women 18 months of contraception through the […]
Theramex wins decentralized procedure approval in EU, UK for hormone drug
Theramex announced today that it received decentralized procedure approval in several EU countries and the UK for its Bijuva capsules. Bijuva possesses an indication for continuous combined hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women with intact uterus and with at least 12 months since last menses, according to a news release. […]
